Good late homograft function was the rule, with all the survivors being free of reoperation for valve failure. At a mean follow-up of 42 +/- 28 months, 41 patients (87% of the survivors ...

[which] appears to refute positive reports about homograft use,” warns Stephen Westaby (Oxford Heart Centre, UK). Further studies to validate these results may also elucidate valve degeneration ...